Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

Rasmus Michael Sandsdal(University of Copenhagen), Signe S. Torekov(University of Copenhagen), Lasse Gliemann(University of Copenhagen), Christian R. Juhl(University of Copenhagen), Jens‐Erik Beck Jensen(University of Copenhagen), Sten Madsbad, Adrian F. Bogh(University of Copenhagen), Bente Stallknecht(University of Copenhagen), Simon Birk Kjær Jensen(University of Copenhagen), Mads Rosenkilde(University of Copenhagen), Jens J. Holst(University of Copenhagen), Charlotte Janus(University of Copenhagen), Charalambos Antoniades(British Heart Foundation), Martin Bæk Blond(University of Copenhagen), J. Lundgren(University of Copenhagen)
Cardiovascular Diabetology
February 25, 2023
10.1186/s12933-023-01765-z
Cited by 157

Related Papers

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data
|The Lancet|2018|1.1k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography
|European Heart Journal|2019|503
Low Physical Activity Accentuates the Effect of the <i>FTO</i> rs9939609 Polymorphism on Body Fat Accumulation
|Diabetes|2007|476
Impact of postprandial glycaemia on health and prevention of disease
|Obesity Reviews|2012|470